Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the lymphatic system (HP:0100763)help
Parent Node:
expand
Abnormality of the lymph nodes (HP:0002733)help
..Starting node
..expand
Lymphadenopathy (HP:0002716)help
Term ID: 2716
Name: Lymphadenopathy
Synonym: Lymph node hyperplasia; Swollen lymph nodes
Definition: Enlargment (swelling) of a lymph node.
Comments:
Reference: HP:0002716
Genes and Diseases:
 
       Child Nodes:
........expandFollicular hyperplasia (HP:0002729) help
........expandChronic noninfectious lymphadenopathy (HP:0002730) help
........expandGeneralized lymphadenopathy (HP:0008940) help
........expandCervical lymphadenopathy (HP:0025289) help
........expandMediastinal lymphadenopathy (HP:0100721) help

 Sister Nodes: 
..expandAbnormality of mesenteric lymph nodes (HP:0025042) help
..expandAbsence of lymph node germinal center (HP:0002849) help
..expandLymph node hypoplasia (HP:0002732) help
..expandLymphadenitis (HP:0002840) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002716HP:0002716Lymphadenopathy0ABCA1 CL E G H1929ORPHA:31150Tangier disease191
HP:0002716HP:0002716Lymphadenopathy0ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation.16
HP:0002716HP:0002716Lymphadenopathy0ADA CL E G H100186ORPHA:39041Omenn syndromeHP:0040281 - Very frequent75
HP:0002716HP:0002716Lymphadenopathy0ADA2 CL E G H518161839OMIM:615688Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome22
HP:0002716HP:0002716Lymphadenopathy0ADAMTS3 CL E G H9508219ORPHA:2136Hennekam syndromeHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0AICDA CL E G H5737913203OMIM:605258Immunodeficiency with hyper-igm, type 2.58
HP:0002716HP:0002716Lymphadenopathy0ANKRD55 CL E G H7972225681ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0APOE CL E G H348613ORPHA:158029Sea-blue histiocytosis39
HP:0002716HP:0002716Lymphadenopathy0ARPC1B CL E G H10095704OMIM:617718Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease.
HP:0002716HP:0002716Lymphadenopathy0ASAH1 CL E G H427735ORPHA:333Farber diseaseHP:0040284 - Very rare78
HP:0002716HP:0002716Lymphadenopathy0ASXL1 CL E G H17102318318ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent145
HP:0002716HP:0002716Lymphadenopathy0ASXL1 CL E G H17102318318ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional145
HP:0002716HP:0002716Lymphadenopathy0ATM CL E G H472795ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent3267
HP:0002716HP:0002716Lymphadenopathy0ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomach169
HP:0002716HP:0002716Lymphadenopathy0BAP1 CL E G H8314950ORPHA:50251Pleural mesotheliomaHP:0040283 - Occasional184
HP:0002716HP:0002716Lymphadenopathy0BCL10 CL E G H8915989ORPHA:52417MALT lymphomaHP:0040283 - Occasional18
HP:0002716HP:0002716Lymphadenopathy0BCL2 CL E G H596990ORPHA:545Follicular lymphomaHP:0040281 - Very frequent1
HP:0002716HP:0002716Lymphadenopathy0BCL6 CL E G H6041001ORPHA:545Follicular lymphomaHP:0040281 - Very frequent1
HP:0002716HP:0002716Lymphadenopathy0BCOR CL E G H5488020893ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional101
HP:0002716HP:0002716Lymphadenopathy0BIRC3 CL E G H330591ORPHA:52417MALT lymphomaHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0BRCA1 CL E G H6721100ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent5769
HP:0002716HP:0002716Lymphadenopathy0BRCA2 CL E G H6751101ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent7642
HP:0002716HP:0002716Lymphadenopathy0BRCA2 CL E G H6751101ORPHA:654NephroblastomaHP:0040283 - Occasional7642
HP:0002716HP:0002716Lymphadenopathy0BTNL2 CL E G H562441142ORPHA:797SarcoidosisHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0BTNL2 CL E G H562441142OMIM:612387Sarcoidosis, susceptibility to, 21
HP:0002716HP:0002716Lymphadenopathy0C4A CL E G H7201323ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0CALR CL E G H8111455ORPHA:824Primary myelofibrosisHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0CARD9 CL E G H6417016391OMIM:212050Candidiasis, familial chronic mucocutaneous, autosomal recessive45
HP:0002716HP:0002716Lymphadenopathy0CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent87
HP:0002716HP:0002716Lymphadenopathy0CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA87
HP:0002716HP:0002716Lymphadenopathy0CASP8 CL E G H8411509OMIM:607271CASPASE 8 DEFICIENCY37
HP:0002716HP:0002716Lymphadenopathy0CBL CL E G H8671541ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent317
HP:0002716HP:0002716Lymphadenopathy0CCBE1 CL E G H14737229426ORPHA:2136Hennekam syndromeHP:0040282 - Frequent147
HP:0002716HP:0002716Lymphadenopathy0CCND1 CL E G H5951582ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent1
HP:0002716HP:0002716Lymphadenopathy0CCND1 CL E G H5951582ORPHA:29073Multiple myelomaHP:0040284 - Very rare1
HP:0002716HP:0002716Lymphadenopathy0CCR1 CL E G H12301602ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0CD19 CL E G H9301633ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent38
HP:0002716HP:0002716Lymphadenopathy0CD19 CL E G H9301633OMIM:240500Immunodeficiency, common variable, 2.38
HP:0002716HP:0002716Lymphadenopathy0CD247 CL E G H9191677ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional8
HP:0002716HP:0002716Lymphadenopathy0CD27 CL E G H93911922OMIM:615122Lymphoproliferative syndrome 24
HP:0002716HP:0002716Lymphadenopathy0CD28 CL E G H9401653ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent
HP:0002716HP:0002716Lymphadenopathy0CD28 CL E G H9401653ORPHA:3162Sézary syndromeHP:0040281 - Very frequent
HP:0002716HP:0002716Lymphadenopathy0CD70 CL E G H97011937OMIM:618261LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3
HP:0002716HP:0002716Lymphadenopathy0CD81 CL E G H9751701ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0CDKN2A CL E G H10291787ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent289
HP:0002716HP:0002716Lymphadenopathy0CHD7 CL E G H5563620626ORPHA:39041Omenn syndromeHP:0040281 - Very frequent515
HP:0002716HP:0002716Lymphadenopathy0CLCN7 CL E G H11862025ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent102
HP:0002716HP:0002716Lymphadenopathy0CR2 CL E G H13802336ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0002716HP:0002716Lymphadenopathy0CR2 CL E G H13802336OMIM:240500Immunodeficiency, common variable, 2.10
HP:0002716HP:0002716Lymphadenopathy0CTLA4 CL E G H14932505OMIM:616100AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS510
HP:0002716HP:0002716Lymphadenopathy0CTLA4 CL E G H14932505ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent10
HP:0002716HP:0002716Lymphadenopathy0CTLA4 CL E G H14932505ORPHA:3162Sézary syndromeHP:0040281 - Very frequent10
HP:0002716HP:0002716Lymphadenopathy0CTNNBL1 CL E G H5625915879OMIM:619846
HP:0002716HP:0002716Lymphadenopathy0CYBA CL E G H15352577ORPHA:379Chronic granulomatous disease27
HP:0002716HP:0002716Lymphadenopathy0CYBA CL E G H15352577OMIM:233690GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE.27
HP:0002716HP:0002716Lymphadenopathy0CYBB CL E G H15362578ORPHA:379Chronic granulomatous disease111
HP:0002716HP:0002716Lymphadenopathy0CYBB CL E G H15362578OMIM:306400Chronic granulomatous disease, X-linked.111
HP:0002716HP:0002716Lymphadenopathy0CYBC1 CL E G H7941528672ORPHA:379Chronic granulomatous disease
HP:0002716HP:0002716Lymphadenopathy0CYBC1 CL E G H7941528672OMIM:618935GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 5; CGD5
HP:0002716HP:0002716Lymphadenopathy0DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomach
HP:0002716HP:0002716Lymphadenopathy0DCLRE1C CL E G H6442117642OMIM:603554Omenn syndrome.94
HP:0002716HP:0002716Lymphadenopathy0DCLRE1C CL E G H6442117642ORPHA:39041Omenn syndromeHP:0040281 - Very frequent94
HP:0002716HP:0002716Lymphadenopathy0DCLRE1C CL E G H6442117642OMIM:602450Severe combined immunodeficiency with sensitivity to ionizing radiation94
HP:0002716HP:0002716Lymphadenopathy0DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0002716HP:0002716Lymphadenopathy0DIS3L2 CL E G H12956328648ORPHA:654NephroblastomaHP:0040283 - Occasional164
HP:0002716HP:0002716Lymphadenopathy0DLEC1 CL E G H99402899ORPHA:99977Squamous cell carcinoma of the esophagusHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0DNASE1L3 CL E G H17762959ORPHA:36412Hypocomplementemic urticarial vasculitisHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0EIF2AK4 CL E G H44027519687ORPHA:199241Pulmonary capillary hemangiomatosisHP:0040281 - Very frequent40
HP:0002716HP:0002716Lymphadenopathy0EIF2AK4 CL E G H44027519687OMIM:234810PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD240
HP:0002716HP:0002716Lymphadenopathy0ELANE CL E G H19913309ORPHA:2686Cyclic neutropeniaHP:0040282 - Frequent79
HP:0002716HP:0002716Lymphadenopathy0ERAP1 CL E G H5175218173ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0EWSR1 CL E G H21303508ORPHA:83469Desmoplastic small round cell tumorHP:0040281 - Very frequent
HP:0002716HP:0002716Lymphadenopathy0FAS CL E G H35511920OMIM:601859Autoimmune lymphoproliferative syndrome59
HP:0002716HP:0002716Lymphadenopathy0FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent59
HP:0002716HP:0002716Lymphadenopathy0FAS CL E G H35511920ORPHA:117Behçet diseaseHP:0040283 - Occasional59
HP:0002716HP:0002716Lymphadenopathy0FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent37
HP:0002716HP:0002716Lymphadenopathy0FASLG CL E G H35611936OMIM:601859Autoimmune lymphoproliferative syndrome37
HP:0002716HP:0002716Lymphadenopathy0FAT4 CL E G H7963323109ORPHA:2136Hennekam syndromeHP:0040282 - Frequent114
HP:0002716HP:0002716Lymphadenopathy0FCHO1 CL E G H2314929002OMIM:619164IMMUNODEFICIENCY 76; IMD76
HP:0002716HP:0002716Lymphadenopathy0FIP1L1 CL E G H8160819124ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional4
HP:0002716HP:0002716Lymphadenopathy0FOXE1 CL E G H23043806ORPHA:319487Familial papillary or follicular thyroid carcinoma9
HP:0002716HP:0002716Lymphadenopathy0FOXP1 CL E G H270863823ORPHA:52417MALT lymphomaHP:0040283 - Occasional184
HP:0002716HP:0002716Lymphadenopathy0FOXP3 CL E G H509436106ORPHA:37042Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndromeHP:0040284 - Very rare32
HP:0002716HP:0002716Lymphadenopathy0FOXP3 CL E G H509436106OMIM:304790Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked32
HP:0002716HP:0002716Lymphadenopathy0GATA2 CL E G H26244171ORPHA:3226Deafness-lymphedema-leukemia syndromeHP:0040283 - Occasional137
HP:0002716HP:0002716Lymphadenopathy0GINS1 CL E G H983728980OMIM:617827Immunodeficiency 55.
HP:0002716HP:0002716Lymphadenopathy0GPC3 CL E G H27194451ORPHA:654NephroblastomaHP:0040283 - Occasional73
HP:0002716HP:0002716Lymphadenopathy0H19 CL E G H2831204713ORPHA:654NephroblastomaHP:0040283 - Occasional4
HP:0002716HP:0002716Lymphadenopathy0HABP2 CL E G H30264798ORPHA:319487Familial papillary or follicular thyroid carcinoma58
HP:0002716HP:0002716Lymphadenopathy0HLA-B CL E G H31064932ORPHA:117Behçet diseaseHP:0040283 - Occasional4
HP:0002716HP:0002716Lymphadenopathy0HLA-B CL E G H31064932ORPHA:397Giant cell arteritis4
HP:0002716HP:0002716Lymphadenopathy0HLA-DPB1 CL E G H31154940ORPHA:133Chronic beryllium disease1
HP:0002716HP:0002716Lymphadenopathy0HLA-DRB1 CL E G H31234948ORPHA:545Follicular lymphomaHP:0040281 - Very frequent2
HP:0002716HP:0002716Lymphadenopathy0HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritis2
HP:0002716HP:0002716Lymphadenopathy0HLA-DRB1 CL E G H31234948ORPHA:797SarcoidosisHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0HLA-DRB1 CL E G H31234948OMIM:181000Sarcoidosis, susceptibility to, 12
HP:0002716HP:0002716Lymphadenopathy0HLA-DRB1 CL E G H31234948ORPHA:85414Systemic-onset juvenile idiopathic arthritisHP:0040282 - Frequent2
HP:0002716HP:0002716Lymphadenopathy0HMOX1 CL E G H31625013OMIM:614034HEME OXYGENASE 1 DEFICIENCY; HMOX1D3
HP:0002716HP:0002716Lymphadenopathy0ICOS CL E G H298515351ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0002716HP:0002716Lymphadenopathy0ICOS CL E G H298515351OMIM:607594Immunodeficiency, common variable, 1.32
HP:0002716HP:0002716Lymphadenopathy0ICOS CL E G H298515351OMIM:240500Immunodeficiency, common variable, 2.32
HP:0002716HP:0002716Lymphadenopathy0IFIH1 CL E G H6413518873OMIM:615846Aicardi-Goutieres syndrome 728
HP:0002716HP:0002716Lymphadenopathy0IFNGR1 CL E G H34595439ORPHA:117Behçet diseaseHP:0040283 - Occasional60
HP:0002716HP:0002716Lymphadenopathy0IFNGR1 CL E G H34595439OMIM:209950Immunodeficiency 27A, mycobacteriosis, AR60
HP:0002716HP:0002716Lymphadenopathy0IFNGR1 CL E G H34595439OMIM:615978Immunodeficiency 27B60
HP:0002716HP:0002716Lymphadenopathy0IGH CL E G H34925477ORPHA:545Follicular lymphomaHP:0040281 - Very frequent7
HP:0002716HP:0002716Lymphadenopathy0IGH CL E G H34925477ORPHA:52417MALT lymphomaHP:0040283 - Occasional7
HP:0002716HP:0002716Lymphadenopathy0IGH CL E G H34925477ORPHA:52416Mantle cell lymphomaHP:0040281 - Very frequent7
HP:0002716HP:0002716Lymphadenopathy0IL10 CL E G H35865962ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0IL12A CL E G H35925969ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0IL12A-AS1 CL E G H10192837649094ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0IL23R CL E G H14923319100ORPHA:117Behçet diseaseHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0IL2RA CL E G H35596008OMIM:606367IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD4165
HP:0002716HP:0002716Lymphadenopathy0IL2RA CL E G H35596008ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional65
HP:0002716HP:0002716Lymphadenopathy0IL2RB CL E G H35606009OMIM:618495Immunodeficiency 63 with lymphoproliferation and autoimmunity.
HP:0002716HP:0002716Lymphadenopathy0IL2RB CL E G H35606009ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0IL2RG CL E G H35616010ORPHA:39041Omenn syndromeHP:0040281 - Very frequent48
HP:0002716HP:0002716Lymphadenopathy0IL6 CL E G H35696018ORPHA:85414Systemic-onset juvenile idiopathic arthritisHP:0040282 - Frequent2
HP:0002716HP:0002716Lymphadenopathy0IL6ST CL E G H35726021OMIM:619750IMMUNODEFICIENCY 94 WITH AUTOINFLAMMATION AND DYSMORPHIC FACIES; IMD94
HP:0002716HP:0002716Lymphadenopathy0IL7R CL E G H35756024ORPHA:39041Omenn syndromeHP:0040281 - Very frequent94
HP:0002716HP:0002716Lymphadenopathy0IL7R CL E G H35756024OMIM:608971Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive.94
HP:0002716HP:0002716Lymphadenopathy0IL7R CL E G H35756024ORPHA:169154T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiencyHP:0040283 - Occasional94
HP:0002716HP:0002716Lymphadenopathy0IRAK1 CL E G H36546112ORPHA:93552Pediatric systemic lupus erythematosusHP:0040282 - Frequent
HP:0002716HP:0002716Lymphadenopathy0IRF2BP2 CL E G H35994821729ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional4
HP:0002716HP:0002716Lymphadenopathy0IRF2BP2 CL E G H35994821729ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent4
HP:0002716HP:0002716Lymphadenopathy0IRF4 CL E G H36626119ORPHA:3452Whipple disease1
HP:0002716HP:0002716Lymphadenopathy0IRF8 CL E G H33945358OMIM:614893IMMUNODEFICIENCY 32A; IMD32A5
HP:0002716HP:0002716Lymphadenopathy0IRF8 CL E G H33945358ORPHA:319600Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiencyHP:0040281 - Very frequent5
HP:0002716HP:0002716Lymphadenopathy0ISG15 CL E G H96364053OMIM:616126Immunodeficiency 38 with basal ganglia calcification4
HP:0002716HP:0002716Lymphadenopathy0ITK CL E G H37026171OMIM:613011LYMPHOPROLIFERATIVE SYNDROME 1; LPFS151
HP:0002716HP:0002716Lymphadenopathy0JAK2 CL E G H37176192ORPHA:824Primary myelofibrosisHP:0040283 - Occasional57
HP:0002716HP:0002716Lymphadenopathy0KIT CL E G H38156342ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional327
HP:0002716HP:0002716Lymphadenopathy0KLRC4 CL E G H83026377ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0KRAS CL E G H38456407ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent196
HP:0002716HP:0002716Lymphadenopathy0KRAS CL E G H38456407OMIM:614470RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic196
HP:0002716HP:0002716Lymphadenopathy0LACC1 CL E G H14481126789ORPHA:85414Systemic-onset juvenile idiopathic arthritisHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0LAT CL E G H2704018874OMIM:617514Immunodeficiency 522
HP:0002716HP:0002716Lymphadenopathy0LCAT CL E G H39316522ORPHA:79292Fish-eye diseaseHP:0040283 - Occasional26
HP:0002716HP:0002716Lymphadenopathy0LIG4 CL E G H39816601ORPHA:99812LIG4 syndromeHP:0040283 - Occasional88
HP:0002716HP:0002716Lymphadenopathy0LIG4 CL E G H39816601ORPHA:39041Omenn syndromeHP:0040281 - Very frequent88
HP:0002716HP:0002716Lymphadenopathy0LRBA CL E G H9871742OMIM:614700IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID845
HP:0002716HP:0002716Lymphadenopathy0LYST CL E G H11301968ORPHA:167Chédiak-Higashi syndromeHP:0040283 - Occasional239
HP:0002716HP:0002716Lymphadenopathy0LYST CL E G H11301968OMIM:214500Chediak-Higashi syndrome239
HP:0002716HP:0002716Lymphadenopathy0MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0002716HP:0002716Lymphadenopathy0MALT1 CL E G H108926819ORPHA:52417MALT lymphomaHP:0040283 - Occasional6
HP:0002716HP:0002716Lymphadenopathy0MCM4 CL E G H41736947OMIM:609981Immunodeficiency 54.69
HP:0002716HP:0002716Lymphadenopathy0MEFV CL E G H42106998ORPHA:117Behçet diseaseHP:0040283 - Occasional281
HP:0002716HP:0002716Lymphadenopathy0MEFV CL E G H42106998ORPHA:342Familial Mediterranean feverHP:0040283 - Occasional281
HP:0002716HP:0002716Lymphadenopathy0MIF CL E G H42827097ORPHA:85414Systemic-onset juvenile idiopathic arthritisHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0MINPP1 CL E G H95627102ORPHA:319487Familial papillary or follicular thyroid carcinoma3
HP:0002716HP:0002716Lymphadenopathy0MPL CL E G H43527217ORPHA:824Primary myelofibrosisHP:0040283 - Occasional97
HP:0002716HP:0002716Lymphadenopathy0MS4A1 CL E G H9317315ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0MVK CL E G H45987530OMIM:260920Hyper-Igd syndrome150
HP:0002716HP:0002716Lymphadenopathy0MVK CL E G H45987530ORPHA:343Hyperimmunoglobulinemia D with periodic feverHP:0040281 - Very frequent150
HP:0002716HP:0002716Lymphadenopathy0MVK CL E G H45987530OMIM:610377Mevalonic aciduria150
HP:0002716HP:0002716Lymphadenopathy0MYD88 CL E G H46157562ORPHA:33226Waldenström macroglobulinemiaHP:0040283 - Occasional9
HP:0002716HP:0002716Lymphadenopathy0NABP1 CL E G H6485926232ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0NCF1 CL E G H6533617660ORPHA:379Chronic granulomatous disease13
HP:0002716HP:0002716Lymphadenopathy0NCF1 CL E G H6533617660OMIM:233700Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type I.13
HP:0002716HP:0002716Lymphadenopathy0NCF2 CL E G H46887661ORPHA:379Chronic granulomatous disease67
HP:0002716HP:0002716Lymphadenopathy0NCF2 CL E G H46887661OMIM:233710Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type II.67
HP:0002716HP:0002716Lymphadenopathy0NCF4 CL E G H46897662ORPHA:379Chronic granulomatous disease37
HP:0002716HP:0002716Lymphadenopathy0NCKAP1L CL E G H30714862OMIM:618982IMMUNODEFICIENCY 72 WITH AUTOINFLAMMATION; IMD72
HP:0002716HP:0002716Lymphadenopathy0NFKB1 CL E G H47907794ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent7
HP:0002716HP:0002716Lymphadenopathy0NFKB2 CL E G H47917795ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent11
HP:0002716HP:0002716Lymphadenopathy0NLRP12 CL E G H9166222938OMIM:611762Familial cold autoinflammatory syndrome 299
HP:0002716HP:0002716Lymphadenopathy0NLRP3 CL E G H11454816400ORPHA:1451CINCA syndromeHP:0040282 - Frequent217
HP:0002716HP:0002716Lymphadenopathy0NLRP3 CL E G H11454816400OMIM:607115CINCA SYNDROME; CINCA217
HP:0002716HP:0002716Lymphadenopathy0NLRP3 CL E G H11454816400OMIM:617772Deafness, autosomal dominant 34, with or without inflammation.217
HP:0002716HP:0002716Lymphadenopathy0NOD2 CL E G H641275331ORPHA:90340Blau syndromeHP:0040283 - Occasional187
HP:0002716HP:0002716Lymphadenopathy0NPM1 CL E G H48697910ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional12
HP:0002716HP:0002716Lymphadenopathy0NRAS CL E G H48937989OMIM:614470RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic102
HP:0002716HP:0002716Lymphadenopathy0NUMA1 CL E G H49268059ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0OTULIN CL E G H9026825118OMIM:617099AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS3
HP:0002716HP:0002716Lymphadenopathy0P4HA2 CL E G H89748547ORPHA:397Giant cell arteritis3
HP:0002716HP:0002716Lymphadenopathy0PALB2 CL E G H7972826144ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent1349
HP:0002716HP:0002716Lymphadenopathy0PALLD CL E G H2302217068ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent192
HP:0002716HP:0002716Lymphadenopathy0PIK3CD CL E G H52938977OMIM:615513IMMUNODEFICIENCY 14; IMD149
HP:0002716HP:0002716Lymphadenopathy0PIK3CG CL E G H52948978OMIM:619802IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION; IMD972
HP:0002716HP:0002716Lymphadenopathy0PML CL E G H53719113ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0POMP CL E G H5137120330OMIM:618048Proteasome-Associated autoinflammatory syndrome 2.2
HP:0002716HP:0002716Lymphadenopathy0POU6F2 CL E G H1128121694ORPHA:654NephroblastomaHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0PRF1 CL E G H55519360ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent58
HP:0002716HP:0002716Lymphadenopathy0PRF1 CL E G H55519360OMIM:603553Hemophagocytic lymphohistiocytosis, familial, 258
HP:0002716HP:0002716Lymphadenopathy0PRKAR1A CL E G H55739388ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional134
HP:0002716HP:0002716Lymphadenopathy0PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent10
HP:0002716HP:0002716Lymphadenopathy0PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0002716HP:0002716Lymphadenopathy0PRKCD CL E G H55809399ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent10
HP:0002716HP:0002716Lymphadenopathy0PSMB4 CL E G H56929541OMIM:617591Proteasome-Associated autoinflammatory syndrome 3.
HP:0002716HP:0002716Lymphadenopathy0PSMB8 CL E G H56969545OMIM:256040Proteasome-associated autoinflammatory syndrome 1 and digenic forms20
HP:0002716HP:0002716Lymphadenopathy0PSMB9 CL E G H56989546OMIM:617591Proteasome-Associated autoinflammatory syndrome 3.
HP:0002716HP:0002716Lymphadenopathy0PSMG2 CL E G H5698424929OMIM:619183PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 4; PRAAS4
HP:0002716HP:0002716Lymphadenopathy0PSTPIP1 CL E G H90519580ORPHA:69126Pyogenic arthritis-pyoderma gangrenosum-acne syndromeHP:0040282 - Frequent96
HP:0002716HP:0002716Lymphadenopathy0PTPN2 CL E G H57719650ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0PTPN22 CL E G H261919652ORPHA:397Giant cell arteritis3
HP:0002716HP:0002716Lymphadenopathy0PTPN22 CL E G H261919652ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0RAB27A CL E G H58739766ORPHA:79477Griscelli syndrome type 2HP:0040282 - Frequent67
HP:0002716HP:0002716Lymphadenopathy0RABL3 CL E G H28528218072ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent
HP:0002716HP:0002716Lymphadenopathy0RAC2 CL E G H58809802OMIM:618986IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B9
HP:0002716HP:0002716Lymphadenopathy0RAC2 CL E G H58809802OMIM:618987IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C9
HP:0002716HP:0002716Lymphadenopathy0RAG1 CL E G H58969831ORPHA:39041Omenn syndromeHP:0040281 - Very frequent127
HP:0002716HP:0002716Lymphadenopathy0RAG1 CL E G H58969831OMIM:603554Omenn syndrome.127
HP:0002716HP:0002716Lymphadenopathy0RAG2 CL E G H58979832ORPHA:39041Omenn syndromeHP:0040281 - Very frequent50
HP:0002716HP:0002716Lymphadenopathy0RAG2 CL E G H58979832OMIM:603554Omenn syndrome.50
HP:0002716HP:0002716Lymphadenopathy0RARA CL E G H59149864ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent
HP:0002716HP:0002716Lymphadenopathy0RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0002716HP:0002716Lymphadenopathy0RBCK1 CL E G H1061615864OMIM:615895Polyglucosan body myopathy 1 with or without immunodeficiencyHP:0040283 - Occasional10
HP:0002716HP:0002716Lymphadenopathy0REST CL E G H59789966ORPHA:654NephroblastomaHP:0040283 - Occasional7
HP:0002716HP:0002716Lymphadenopathy0RIPK1 CL E G H873710019OMIM:618852AUTOINFLAMMATION WITH EPISODIC FEVER AND LYMPHADENOPATHY; AIEFL
HP:0002716HP:0002716Lymphadenopathy0RMRP CL E G H602310031ORPHA:39041Omenn syndromeHP:0040281 - Very frequent37
HP:0002716HP:0002716Lymphadenopathy0RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndrome7
HP:0002716HP:0002716Lymphadenopathy0RNF6 CL E G H604910069ORPHA:99977Squamous cell carcinoma of the esophagusHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0RNU4ATAC CL E G H10015168334016OMIM:616651Roifman syndrome.15
HP:0002716HP:0002716Lymphadenopathy0RNU4ATAC CL E G H10015168334016ORPHA:353298Roifman syndromeHP:0040282 - Frequent15
HP:0002716HP:0002716Lymphadenopathy0RUNX1 CL E G H86110471ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent181
HP:0002716HP:0002716Lymphadenopathy0SDHD CL E G H639210683ORPHA:100093Carcinoid syndrome129
HP:0002716HP:0002716Lymphadenopathy0SH2D1A CL E G H406810820OMIM:308240Lymphoproliferative syndrome, X-linked, 137
HP:0002716HP:0002716Lymphadenopathy0SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0002716HP:0002716Lymphadenopathy0SLC29A3 CL E G H5531523096ORPHA:168569H syndromeHP:0040282 - Frequent68
HP:0002716HP:0002716Lymphadenopathy0SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0002716HP:0002716Lymphadenopathy0SMAD4 CL E G H40896770ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent504
HP:0002716HP:0002716Lymphadenopathy0SMPD1 CL E G H660911120OMIM:257200Niemann-Pick disease, type A.164
HP:0002716HP:0002716Lymphadenopathy0SNX10 CL E G H2988714974ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent2
HP:0002716HP:0002716Lymphadenopathy0SOCS1 CL E G H865119383OMIM:619375AUTOINFLAMMATORY SYNDROME, FAMILIAL, WITH OR WITHOUT IMMUNODEFICIENCY; AISIMD6
HP:0002716HP:0002716Lymphadenopathy0SPP1 CL E G H669611255ORPHA:93552Pediatric systemic lupus erythematosusHP:0040282 - Frequent
HP:0002716HP:0002716Lymphadenopathy0SRSF2 CL E G H642710783ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0SRSF2 CL E G H642710783ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0STAT1 CL E G H677211362OMIM:614162Immunodeficiency 31C89
HP:0002716HP:0002716Lymphadenopathy0STAT3 CL E G H677411364ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional110
HP:0002716HP:0002716Lymphadenopathy0STAT4 CL E G H677511365ORPHA:117Behçet diseaseHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0STAT4 CL E G H677511365ORPHA:93552Pediatric systemic lupus erythematosusHP:0040282 - Frequent2
HP:0002716HP:0002716Lymphadenopathy0STAT4 CL E G H677511365ORPHA:85408Rheumatoid factor-negative polyarticular juvenile idiopathic arthritisHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0STAT5B CL E G H677711367ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional12
HP:0002716HP:0002716Lymphadenopathy0STIM1 CL E G H678611386OMIM:612783Immunodeficiency 10.31
HP:0002716HP:0002716Lymphadenopathy0STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0002716HP:0002716Lymphadenopathy0STX11 CL E G H867611429ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent85
HP:0002716HP:0002716Lymphadenopathy0STX11 CL E G H867611429OMIM:603552HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL485
HP:0002716HP:0002716Lymphadenopathy0STXBP2 CL E G H681311445ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent70
HP:0002716HP:0002716Lymphadenopathy0STXBP2 CL E G H681311445OMIM:613101HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL570
HP:0002716HP:0002716Lymphadenopathy0SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0002716HP:0002716Lymphadenopathy0TBL1XR1 CL E G H7971829529ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional22
HP:0002716HP:0002716Lymphadenopathy0TCIRG1 CL E G H1031211647ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent82
HP:0002716HP:0002716Lymphadenopathy0TERT CL E G H701511730OMIM:614742PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1238
HP:0002716HP:0002716Lymphadenopathy0TET2 CL E G H5479025941ORPHA:98850Aggressive systemic mastocytosisHP:0040282 - Frequent3
HP:0002716HP:0002716Lymphadenopathy0TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0002716HP:0002716Lymphadenopathy0TET2 CL E G H5479025941ORPHA:824Primary myelofibrosisHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0TET2 CL E G H5479025941ORPHA:98849Systemic mastocytosis with associated hematologic neoplasmHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0TGFBR2 CL E G H704811773ORPHA:99977Squamous cell carcinoma of the esophagusHP:0040283 - Occasional253
HP:0002716HP:0002716Lymphadenopathy0TLR4 CL E G H709911850ORPHA:117Behçet diseaseHP:0040283 - Occasional3
HP:0002716HP:0002716Lymphadenopathy0TLR8 CL E G H5131115632OMIM:301078IMMUNODEFICIENCY 98 WITH AUTOINFLAMMATION, X-LINKED; IMD98
HP:0002716HP:0002716Lymphadenopathy0TNFRSF13B CL E G H2349518153ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent32
HP:0002716HP:0002716Lymphadenopathy0TNFRSF13B CL E G H2349518153OMIM:240500Immunodeficiency, common variable, 2.32
HP:0002716HP:0002716Lymphadenopathy0TNFRSF13C CL E G H11565017755ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent12
HP:0002716HP:0002716Lymphadenopathy0TNFRSF13C CL E G H11565017755OMIM:240500Immunodeficiency, common variable, 2.12
HP:0002716HP:0002716Lymphadenopathy0TNFRSF1A CL E G H713211916OMIM:142680Periodic fever, familial, autosomal dominant131
HP:0002716HP:0002716Lymphadenopathy0TNFRSF1A CL E G H713211916ORPHA:32960Tumor necrosis factor receptor 1 associated periodic syndromeHP:0040282 - Frequent131
HP:0002716HP:0002716Lymphadenopathy0TNFRSF1B CL E G H713311917ORPHA:2584Classic mycosis fungoidesHP:0040282 - Frequent
HP:0002716HP:0002716Lymphadenopathy0TNFRSF1B CL E G H713311917ORPHA:3162Sézary syndromeHP:0040281 - Very frequent
HP:0002716HP:0002716Lymphadenopathy0TNFSF11 CL E G H860011926ORPHA:667Autosomal recessive malignant osteopetrosisHP:0040281 - Very frequent44
HP:0002716HP:0002716Lymphadenopathy0TNFSF12 CL E G H874211927ORPHA:1572Common variable immunodeficiencyHP:0040282 - Frequent1
HP:0002716HP:0002716Lymphadenopathy0TP53 CL E G H715711998ORPHA:1333Familial pancreatic carcinomaHP:0040282 - Frequent911
HP:0002716HP:0002716Lymphadenopathy0TPP2 CL E G H717412016ORPHA:444463Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndromeHP:0040281 - Very frequent
HP:0002716HP:0002716Lymphadenopathy0TPP2 CL E G H717412016OMIM:619220IMMUNODEFICIENCY 78 WITH AUTOIMMUNITY AND DEVELOPMENTAL DELAY; IMD78
HP:0002716HP:0002716Lymphadenopathy0TRAC CL E G H2875512029OMIM:615387T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY.1
HP:0002716HP:0002716Lymphadenopathy0TRIM28 CL E G H1015516384ORPHA:654NephroblastomaHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0TRIP13 CL E G H931912307ORPHA:654NephroblastomaHP:0040283 - Occasional2
HP:0002716HP:0002716Lymphadenopathy0TSC1 CL E G H724812362ORPHA:538LymphangioleiomyomatosisHP:0040282 - Frequent1090
HP:0002716HP:0002716Lymphadenopathy0TSC2 CL E G H724912363ORPHA:538LymphangioleiomyomatosisHP:0040282 - Frequent2738
HP:0002716HP:0002716Lymphadenopathy0UBAC2 CL E G H33786720486ORPHA:117Behçet diseaseHP:0040283 - Occasional
HP:0002716HP:0002716Lymphadenopathy0UNC13D CL E G H20129423147ORPHA:540Familial hemophagocytic lymphohistiocytosisHP:0040282 - Frequent116
HP:0002716HP:0002716Lymphadenopathy0UNG CL E G H737412572OMIM:608106Immunodeficiency with hyper-igm, type 5.44
HP:0002716HP:0002716Lymphadenopathy0WDR1 CL E G H994812754OMIM:150550Periodic fever, immunodeficiency, and thrombocytopenia syndrome
HP:0002716HP:0002716Lymphadenopathy0WT1 CL E G H749012796ORPHA:83469Desmoplastic small round cell tumorHP:0040281 - Very frequent177
HP:0002716HP:0002716Lymphadenopathy0WT1 CL E G H749012796ORPHA:654NephroblastomaHP:0040283 - Occasional177
HP:0002716HP:0002716Lymphadenopathy0WWOX CL E G H5174112799ORPHA:99977Squamous cell carcinoma of the esophagusHP:0040283 - Occasional149
HP:0002716HP:0002716Lymphadenopathy0XIAP CL E G H331592OMIM:308240Lymphoproliferative syndrome, X-linked, 181
HP:0002716HP:0002716Lymphadenopathy0XRCC4 CL E G H751812831ORPHA:99812LIG4 syndromeHP:0040283 - Occasional9
HP:0002716HP:0002716Lymphadenopathy0YARS1 CL E G H856512840OMIM:619418NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET 2; IMNEPD2
HP:0002716HP:0002716Lymphadenopathy0ZAP70 CL E G H753512858ORPHA:911Combined immunodeficiency due to ZAP70 deficiencyHP:0040283 - Occasional46
HP:0002716HP:0002716Lymphadenopathy0ZBTB16 CL E G H770412930ORPHA:520Acute promyelocytic leukemiaHP:0040283 - Occasional1
HP:0002716HP:0002716Lymphadenopathy0ZNFX1 CL E G H5716929271OMIM:619644IMMUNODEFICIENCY 91 AND HYPERINFLAMMATION; IMD91
HP:0002716HP:0034388Hilar lymph node enlargement1 CL E G H
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1ABCA1 CL E G H1929ORPHA:31150Tangier diseaseHP:0040282 - Frequent191
HP:0002716HP:0100721Mediastinal lymphadenopathy1APOE CL E G H348613ORPHA:158029Sea-blue histiocytosisHP:0040281 - Very frequent39
HP:0002716HP:0025289Cervical lymphadenopathy1ARPC1B CL E G H10095704OMIM:617718Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1ATRX CL E G H546886ORPHA:100075Neuroendocrine tumor of stomachHP:0040283 - Occasional169
HP:0002716HP:0100721Mediastinal lymphadenopathy1BCL10 CL E G H8915989ORPHA:52417MALT lymphomaHP:0040283 - Occasional18
HP:0002716HP:0100721Mediastinal lymphadenopathy1BCL2 CL E G H596990ORPHA:545Follicular lymphomaHP:0040281 - Very frequent1
HP:0002716HP:0100721Mediastinal lymphadenopathy1BCL6 CL E G H6041001ORPHA:545Follicular lymphomaHP:0040281 - Very frequent1
HP:0002716HP:0100721Mediastinal lymphadenopathy1BIRC3 CL E G H330591ORPHA:52417MALT lymphomaHP:0040283 - Occasional
HP:0002716HP:0100721Mediastinal lymphadenopathy1BTNL2 CL E G H562441142OMIM:612387Sarcoidosis, susceptibility to, 21
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1CASP10 CL E G H8431500ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent87
HP:0002716HP:0002729Follicular hyperplasia1CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA.87
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1CASP10 CL E G H8431500OMIM:603909Autoimmune lymphoproliferative syndrome, type IIA.87
HP:0002716HP:0002729Follicular hyperplasia1CD19 CL E G H9301633OMIM:240500Immunodeficiency, common variable, 2.38
HP:0002716HP:0002729Follicular hyperplasia1CR2 CL E G H13802336OMIM:240500Immunodeficiency, common variable, 2.10
HP:0002716HP:0002729Follicular hyperplasia1CTNNBL1 CL E G H5625915879OMIM:619846
HP:0002716HP:0100721Mediastinal lymphadenopathy1CYBA CL E G H15352577ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent27
HP:0002716HP:0100721Mediastinal lymphadenopathy1CYBB CL E G H15362578ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent111
HP:0002716HP:0100721Mediastinal lymphadenopathy1CYBC1 CL E G H7941528672ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1DAXX CL E G H16162681ORPHA:100075Neuroendocrine tumor of stomachHP:0040283 - Occasional
HP:0002716HP:0008940Generalized lymphadenopathy1DCLRE1C CL E G H6442117642OMIM:602450Severe combined immunodeficiency with sensitivity to ionizing radiation94
HP:0002716HP:0025289Cervical lymphadenopathy1DEF6 CL E G H506192760OMIM:619573IMMUNODEFICIENCY 87 AND AUTOIMMUNITY; IMD87
HP:0002716HP:0100721Mediastinal lymphadenopathy1EIF2AK4 CL E G H44027519687ORPHA:199241Pulmonary capillary hemangiomatosisHP:0040282 - Frequent40
HP:0002716HP:0100721Mediastinal lymphadenopathy1EIF2AK4 CL E G H44027519687OMIM:234810PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD240
HP:0002716HP:0025289Cervical lymphadenopathy1ELANE CL E G H19913309ORPHA:2686Cyclic neutropeniaHP:0040282 - Frequent79
HP:0002716HP:0100721Mediastinal lymphadenopathy1EWSR1 CL E G H21303508ORPHA:83469Desmoplastic small round cell tumorHP:0040282 - Frequent
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1FAS CL E G H35511920OMIM:601859Autoimmune lymphoproliferative syndrome.59
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1FAS CL E G H35511920ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent59
HP:0002716HP:0002729Follicular hyperplasia1FAS CL E G H35511920OMIM:601859Autoimmune lymphoproliferative syndrome.59
HP:0002716HP:0002729Follicular hyperplasia1FASLG CL E G H35611936OMIM:601859Autoimmune lymphoproliferative syndrome.37
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1FASLG CL E G H35611936ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent37
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1FASLG CL E G H35611936OMIM:601859Autoimmune lymphoproliferative syndrome.37
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1FOXE1 CL E G H23043806ORPHA:319487Familial papillary or follicular thyroid carcinomaHP:0040282 - Frequent9
HP:0002716HP:0100721Mediastinal lymphadenopathy1FOXP1 CL E G H270863823ORPHA:52417MALT lymphomaHP:0040283 - Occasional184
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1HABP2 CL E G H30264798ORPHA:319487Familial papillary or follicular thyroid carcinomaHP:0040282 - Frequent58
HP:0002716HP:0100721Mediastinal lymphadenopathy1HLA-B CL E G H31064932ORPHA:397Giant cell arteritisHP:0040283 - Occasional4
HP:0002716HP:0100721Mediastinal lymphadenopathy1HLA-DPB1 CL E G H31154940ORPHA:133Chronic beryllium diseaseHP:0040283 - Occasional1
HP:0002716HP:0100721Mediastinal lymphadenopathy1HLA-DRB1 CL E G H31234948ORPHA:545Follicular lymphomaHP:0040281 - Very frequent2
HP:0002716HP:0100721Mediastinal lymphadenopathy1HLA-DRB1 CL E G H31234948ORPHA:397Giant cell arteritisHP:0040283 - Occasional2
HP:0002716HP:0008940Generalized lymphadenopathy1HLA-DRB1 CL E G H31234948OMIM:181000Sarcoidosis, susceptibility to, 1.2
HP:0002716HP:0100721Mediastinal lymphadenopathy1HLA-DRB1 CL E G H31234948OMIM:181000Sarcoidosis, susceptibility to, 12
HP:0002716HP:0025289Cervical lymphadenopathy1HMOX1 CL E G H31625013OMIM:614034HEME OXYGENASE 1 DEFICIENCY; HMOX1D3
HP:0002716HP:0002729Follicular hyperplasia1ICOS CL E G H298515351OMIM:240500Immunodeficiency, common variable, 2.32
HP:0002716HP:0008940Generalized lymphadenopathy1IFIH1 CL E G H6413518873OMIM:615846Aicardi-Goutieres syndrome 728
HP:0002716HP:0008940Generalized lymphadenopathy1IFNGR1 CL E G H34595439OMIM:615978Immunodeficiency 27B60
HP:0002716HP:0100721Mediastinal lymphadenopathy1IGH CL E G H34925477ORPHA:545Follicular lymphomaHP:0040281 - Very frequent7
HP:0002716HP:0100721Mediastinal lymphadenopathy1IGH CL E G H34925477ORPHA:52417MALT lymphomaHP:0040283 - Occasional7
HP:0002716HP:0100721Mediastinal lymphadenopathy1IRF4 CL E G H36626119ORPHA:3452Whipple diseaseHP:0040281 - Very frequent1
HP:0002716HP:0002729Follicular hyperplasia1KRAS CL E G H38456407OMIM:614470RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic.196
HP:0002716HP:0008940Generalized lymphadenopathy1LRBA CL E G H9871742OMIM:614700IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID845
HP:0002716HP:0100721Mediastinal lymphadenopathy1MAGT1 CL E G H8406128880OMIM:300853IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS INFECTION, AND NEOPLASIA; XMEN17
HP:0002716HP:0100721Mediastinal lymphadenopathy1MALT1 CL E G H108926819ORPHA:52417MALT lymphomaHP:0040283 - Occasional6
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1MINPP1 CL E G H95627102ORPHA:319487Familial papillary or follicular thyroid carcinomaHP:0040282 - Frequent3
HP:0002716HP:0100721Mediastinal lymphadenopathy1NCF1 CL E G H6533617660ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent13
HP:0002716HP:0100721Mediastinal lymphadenopathy1NCF2 CL E G H46887661ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent67
HP:0002716HP:0100721Mediastinal lymphadenopathy1NCF4 CL E G H46897662ORPHA:379Chronic granulomatous diseaseHP:0040281 - Very frequent37
HP:0002716HP:0002729Follicular hyperplasia1NRAS CL E G H48937989OMIM:614470RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic.102
HP:0002716HP:0100721Mediastinal lymphadenopathy1P4HA2 CL E G H89748547ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0002716HP:0100721Mediastinal lymphadenopathy1PIK3CG CL E G H52948978OMIM:619802IMMUNODEFICIENCY 97 WITH AUTOINFLAMMATION; IMD972
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1PRKCD CL E G H55809399ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent10
HP:0002716HP:0008940Generalized lymphadenopathy1PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0002716HP:0100721Mediastinal lymphadenopathy1PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0002716HP:0002729Follicular hyperplasia1PRKCD CL E G H55809399OMIM:615559AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS310
HP:0002716HP:0100721Mediastinal lymphadenopathy1PTPN22 CL E G H261919652ORPHA:397Giant cell arteritisHP:0040283 - Occasional3
HP:0002716HP:0008940Generalized lymphadenopathy1RAC2 CL E G H58809802OMIM:618986IMMUNODEFICIENCY 73B WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND LYMPHOPENIA; IMD73B9
HP:0002716HP:0025289Cervical lymphadenopathy1RAC2 CL E G H58809802OMIM:618987IMMUNODEFICIENCY 73C WITH DEFECTIVE NEUTROPHIL CHEMOTAXIS AND HYPOGAMMAGLOBULINEMIA; IMD73C9
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1RASGRP1 CL E G H101259878ORPHA:3261Autoimmune lymphoproliferative syndromeHP:0040281 - Very frequent
HP:0002716HP:0025289Cervical lymphadenopathy1RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0002716HP:0100721Mediastinal lymphadenopathy1RASGRP1 CL E G H101259878OMIM:618534IMMUNODEFICIENCY 64; IMD64
HP:0002716HP:0008940Generalized lymphadenopathy1RNF168 CL E G H16591826661ORPHA:420741RIDDLE syndromeHP:0040283 - Occasional7
HP:0002716HP:0002730Chronic noninfectious lymphadenopathy1SDHD CL E G H639210683ORPHA:100093Carcinoid syndromeHP:0040283 - Occasional129
HP:0002716HP:0033176Submandibular lymph node enlargement1SH3BP2 CL E G H645210825OMIM:118400Cherubism177
HP:0002716HP:0025289Cervical lymphadenopathy1SLC29A3 CL E G H5531523096OMIM:602782Histiocytosis-lymphadenopathy plus syndrome68
HP:0002716HP:0002729Follicular hyperplasia1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0002716HP:0033280Paratracheal lymphadenopathy1STING1 CL E G H34006127962OMIM:615934STING-associated vasculopathy, infantile-onset
HP:0002716HP:0002729Follicular hyperplasia1SYK CL E G H685011491OMIM:619381IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION; IMD821
HP:0002716HP:0100721Mediastinal lymphadenopathy1TERT CL E G H701511730OMIM:614742PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1238
HP:0002716HP:0002729Follicular hyperplasia1TET2 CL E G H5479025941OMIM:619126IMMUNODEFICIENCY 75; IMD753
HP:0002716HP:0002729Follicular hyperplasia1TNFRSF13B CL E G H2349518153OMIM:240500Immunodeficiency, common variable, 2.32
HP:0002716HP:0002729Follicular hyperplasia1TNFRSF13C CL E G H11565017755OMIM:240500Immunodeficiency, common variable, 2.12
HP:0002716HP:0025289Cervical lymphadenopathy1TNFRSF1A CL E G H713211916OMIM:142680Periodic fever, familial, autosomal dominant131
HP:0002716HP:0100721Mediastinal lymphadenopathy1WT1 CL E G H749012796ORPHA:83469Desmoplastic small round cell tumorHP:0040282 - Frequent177


Genes (211) :ABCA1 ACP5 ADA ADA2 ADAMTS3 AICDA ANKRD55 APOE ARPC1B ASAH1 ASXL1 ATM ATRX BAP1 BCL10 BCL2 BCL6 BCOR BIRC3 BRCA1 BRCA2 BTNL2 C4A CALR CARD9 CASP10 CASP8 CBL CCBE1 CCND1 CCR1 CD19 CD247 CD27 CD28 CD70 CD81 CDKN2A CHD7 CLCN7 CR2 CTLA4 CTNNBL1 CYBA CYBB CYBC1 DAXX DCLRE1C DEF6 DIS3L2 DLEC1 DNASE1L3 EIF2AK4 ELANE ERAP1 EWSR1 FAS FASLG FAT4 FCHO1 FIP1L1 FOXE1 FOXP1 FOXP3 GATA2 GINS1 GPC3 H19 HABP2 HLA-B HLA-DPB1 HLA-DRB1 HMOX1 ICOS IFIH1 IFNGR1 IGH IL10 IL12A IL12A-AS1 IL23R IL2RA IL2RB IL2RG IL6 IL6ST IL7R IRAK1 IRF2BP2 IRF4 IRF8 ISG15 ITK JAK2 KIT KLRC4 KRAS LACC1 LAT LCAT LIG4 LRBA LYST MAGT1 MALT1 MCM4 MEFV MIF MINPP1 MPL MS4A1 MVK MYD88 NABP1 NCF1 NCF2 NCF4 NCKAP1L NFKB1 NFKB2 NLRP12 NLRP3 NOD2 NPM1 NRAS NUMA1 OTULIN P4HA2 PALB2 PALLD PIK3CD PIK3CG PML POMP POU6F2 PRF1 PRKAR1A PRKCD PSMB4 PSMB8 PSMB9 PSMG2 PSTPIP1 PTPN2 PTPN22 RAB27A RABL3 RAC2 RAG1 RAG2 RARA RASGRP1 RBCK1 REST RIPK1 RMRP RNF168 RNF6 RNU4ATAC RUNX1 SDHD SH2D1A SH3BP2 SLC29A3 SMAD4 SMPD1 SNX10 SOCS1 SPP1 SRSF2 STAT1 STAT3 STAT4 STAT5B STIM1 STING1 STX11 STXBP2 SYK TBL1XR1 TCIRG1 TERT TET2 TGFBR2 TLR4 TLR8 TNFRSF13B TNFRSF13C TNFRSF1A TNFRSF1B TNFSF11 TNFSF12 TP53 TPP2 TRAC TRIM28 TRIP13 TSC1 TSC2 UBAC2 UNC13D UNG WDR1 WT1 WWOX XIAP XRCC4 YARS1 ZAP70 ZBTB16 ZNFX1

Diseases (147) :ORPHA:31150 OMIM:607944 ORPHA:39041 OMIM:615688 ORPHA:2136 OMIM:605258 ORPHA:85408 ORPHA:158029 OMIM:617718 ORPHA:333 ORPHA:98850 ORPHA:98849 ORPHA:52416 ORPHA:100075 ORPHA:50251 ORPHA:52417 ORPHA:545 ORPHA:520 ORPHA:1333 ORPHA:654 ORPHA:797 OMIM:612387 ORPHA:117 ORPHA:824 OMIM:212050 ORPHA:3261 OMIM:603909 OMIM:607271 ORPHA:29073 ORPHA:1572 OMIM:240500 OMIM:615122 ORPHA:2584 ORPHA:3162 OMIM:618261 ORPHA:667 OMIM:616100 OMIM:619846 ORPHA:379 OMIM:233690 OMIM:306400 OMIM:618935 OMIM:603554 OMIM:602450 OMIM:619573 ORPHA:99977 ORPHA:36412 ORPHA:199241 OMIM:234810 ORPHA:2686 ORPHA:83469 OMIM:601859 OMIM:619164 ORPHA:319487 ORPHA:37042 OMIM:304790 ORPHA:3226 OMIM:617827 ORPHA:397 ORPHA:133 OMIM:181000 ORPHA:85414 OMIM:614034 OMIM:607594 OMIM:615846 OMIM:209950 OMIM:615978 OMIM:606367 OMIM:618495 OMIM:619750 OMIM:608971 ORPHA:169154 ORPHA:93552 ORPHA:3452 OMIM:614893 ORPHA:319600 OMIM:616126 OMIM:613011 OMIM:614470 OMIM:617514 ORPHA:79292 ORPHA:99812 OMIM:614700 ORPHA:167 OMIM:214500 OMIM:300853 OMIM:609981 ORPHA:342 OMIM:260920 ORPHA:343 OMIM:610377 ORPHA:33226 OMIM:233700 OMIM:233710 OMIM:618982 OMIM:611762 ORPHA:1451 OMIM:607115 OMIM:617772 ORPHA:90340 OMIM:617099 OMIM:615513 OMIM:619802 OMIM:618048 ORPHA:540 OMIM:603553 OMIM:615559 OMIM:617591 OMIM:256040 OMIM:619183 ORPHA:69126 ORPHA:79477 OMIM:618986 OMIM:618987 OMIM:618534 OMIM:615895 OMIM:618852 ORPHA:420741 OMIM:616651 ORPHA:353298 ORPHA:100093 OMIM:308240 OMIM:118400 ORPHA:168569 OMIM:602782 OMIM:257200 OMIM:619375 OMIM:614162 OMIM:612783 OMIM:615934 OMIM:603552 OMIM:613101 OMIM:619381 OMIM:614742 OMIM:619126 OMIM:301078 OMIM:142680 ORPHA:32960 ORPHA:444463 OMIM:619220 OMIM:615387 ORPHA:538 OMIM:608106 OMIM:150550 OMIM:619418 ORPHA:911 OMIM:619644
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.